fecal
secretori
immunoglobulin
iga
antibodi
dog
infect
vaccin
canin
coronaviru
ccv
evalu
enzymelink
immunosorb
assay
studi
carri
fecal
sampl
collect
inocul
day
postinocul
five
group
studi
natur
infect
dog
experiment
infect
dog
dog
inocul
modifi
live
ml
ccv
vaccin
intramuscular
rout
dog
inocul
ml
ccv
vaccin
oronas
rout
dog
given
inactiv
ccv
vaccin
natur
experiment
infect
dog
develop
high
level
fecal
iga
interestingli
dog
inocul
ml
ccv
vaccin
oronas
rout
develop
level
fecal
iga
higher
observ
dog
inocul
ccv
vaccin
intramuscular
rout
observ
dog
inocul
inactiv
vaccin
relationship
level
fecal
iga
ccv
degre
protect
ccv
infect
observ
canin
coronaviru
ccv
enter
pathogen
dog
respons
mild
sever
diarrhea
pup
uncompl
ccv
infect
consid
minor
clinic
import
dual
infect
eg
ccvcanin
parvoviru
type
ccvcanin
adenoviru
type
infect
observ
sever
ill
pup
ccv
shed
fece
natur
infect
pup
previous
demonstr
period
day
recent
longterm
viral
shed
day
observ
observ
led
us
consid
immun
dog
ccv
would
favor
epidemiolog
effect
data
durat
immun
infect
pup
avail
although
serum
antibodi
titer
pup
infect
vaccin
intramuscular
rout
gener
higher
oral
expos
pup
immun
occur
subsequ
oral
infect
ccv
known
mucos
surfac
gastrointestin
tract
replet
organ
follicl
antigenreact
lymphoid
tissu
includ
b
cell
lymphocyt
plasma
cell
cellular
element
involv
induct
mainten
immun
respons
gutassoci
lymphoid
tissu
consid
princip
induct
site
mucos
immun
respons
extern
secret
secretori
immunoglobulin
iga
involv
defend
extern
surfac
inhibit
adher
sever
pathogen
surfac
mucos
cell
therebi
prevent
entri
pathogen
secretori
iga
contribut
immun
exclus
complex
antigen
limit
lumin
uptak
consequ
protect
mucos
infect
gener
correl
presenc
specif
antibodi
mucos
surfac
sever
studi
suggest
import
antibodi
mucos
surfac
small
intestin
major
determin
resist
rotaviru
ill
therefor
appear
local
immun
iga
gut
mucosa
essenti
protect
ccv
infect
aim
studi
evalu
enzymelink
immunosorb
assay
elisa
level
fecal
iga
ccv
dog
follow
infect
vaccin
statist
compar
result
obtain
order
defin
effect
mode
vaccin
previou
studi
fecal
sampl
collect
dog
ccv
infect
vaccin
fecal
sampl
collect
experiment
infect
vaccin
time
zero
day
postinocul
fecal
sampl
natur
infect
dog
collect
begin
enter
ill
day
later
sampl
store
examin
group
studi
group
includ
four
fecal
sampl
collect
two
natur
infect
dog
whose
infect
confirm
pcr
assay
ccv
group
b
includ
four
sampl
collect
two
dog
experiment
infect
ccv
group
c
includ
eight
sampl
collect
four
dog
vaccin
intramuscular
rout
experiment
modifi
live
ml
ccv
vaccin
group
includ
eight
sampl
collect
four
dog
vaccin
experiment
ml
ccv
vaccin
oronas
rout
group
e
includ
eight
sampl
collect
four
dog
vaccin
intramuscular
rout
inactiv
commerci
ccv
vaccin
elisa
fecal
iga
ccvspecif
iga
fecal
sampl
determin
elisa
antigen
elisa
prepar
previous
describ
briefli
supernat
crandel
felin
kidney
cell
cultur
infect
ccv
strain
harvest
h
postinfect
clarifi
g
min
centrifug
g
h
microtit
plate
coat
l
ccv
antigen
dilut
carbon
buffer
mm
na
co
mm
nahco
ph
per
well
incub
overnight
slow
shake
plate
wash
four
time
phosphatebuff
salin
contain
tween
pbst
treat
block
solut
gelatin
carbon
buffer
min
wash
four
time
pbst
dilut
fecal
sampl
pbst
ad
duplic
plate
incub
min
wash
cycl
repeat
l
goat
antidog
igahorseradish
peroxidas
conjug
bethyl
laboratori
inc
montgomeri
tex
dilut
pbst
ad
well
plate
incub
h
wash
cycl
mg
freshli
prepar
substrat
sulfon
diammonium
salt
abt
sigma
chemic
co
st
loui
mo
ml
phosphat
citrat
buffer
ph
place
well
optic
densiti
nm
od
determin
adjust
od
valu
sampl
obtain
subtract
od
mock
antigenco
well
correspond
viru
antigenco
well
cutoff
valu
od
defin
mean
od
plu
standard
deviat
calcul
neg
fecal
sampl
collect
dog
separ
hous
previous
examin
ccv
antigen
fece
antibodi
serum
serum
antibodi
determin
serolog
test
blood
sampl
collect
dog
day
fecal
sampl
viru
neutral
vn
test
elisa
carri
previous
describ
goat
antidog
igg
sigma
chemic
co
use
latter
test
statist
analysi
statist
analysi
carri
compar
antibodi
level
five
experiment
group
fecal
secretori
iga
antibodi
level
measur
fecal
optic
densiti
fod
well
serum
antibodi
level
determin
vn
serum
vn
svn
elisa
serum
optic
densiti
sod
first
submit
normal
test
univari
procedur
due
deviat
normal
detect
origin
variabl
fod
svn
logarithm
transform
natur
logarithm
lnfod
lnsvn
appli
order
submit
data
analysi
varianc
sinc
sod
distribut
significantli
differ
normal
logarithm
transform
carri
variabl
oneway
analysi
varianc
perform
gener
linear
model
procedur
fit
linear
model
ij
g
e
ij
ij
jth
observ
depend
variabl
time
time
variabl
analyz
lnfod
lnsvn
sod
overal
mean
g
fix
effect
ith
group
five
level
correspond
experiment
group
b
c
e
e
ij
residu
error
model
solut
leastsquar
mean
lsm
calcul
depend
variabl
statist
signific
differ
experiment
group
evalu
test
bonferroni
correct
appli
multipl
comparison
result
test
antibodi
ccv
serum
sampl
fecal
sampl
report
tabl
sera
two
dog
natur
infect
ccv
group
test
neg
vn
test
titer
elisa
median
od
valu
high
level
neutral
antibodi
titer
high
od
valu
elisa
median
od
valu
found
dog
elisadetect
iga
od
valu
higher
median
od
valu
respect
sera
dog
experiment
infect
ccv
group
b
neg
vn
test
titer
elisa
median
od
valu
high
antibodi
titer
vn
test
titer
respect
elisa
median
od
valu
elisadetect
iga
antibodi
median
od
valu
remain
rel
low
level
median
od
valu
four
dog
inocul
intramuscular
rout
ml
ccv
vaccin
group
c
test
neg
vn
test
titer
elisa
median
od
valu
howev
low
vn
titer
median
od
valu
detect
differ
found
iga
valu
median
od
valu
respect
four
dog
inocul
ml
ccv
vaccin
oronas
rout
group
test
neg
vn
test
titer
elisa
median
od
valu
serum
antibodi
level
dog
increas
accord
vn
test
titer
elisa
median
od
valu
elisadetect
iga
median
od
valu
serum
sampl
four
dog
inocul
inactiv
ccv
vaccin
group
e
test
neg
vn
test
titer
elisa
median
od
valu
even
though
serolog
respons
could
detect
vn
test
titer
elisa
median
od
valu
iga
level
fecal
sampl
similar
observ
median
od
valu
respect
statist
evalu
vaccin
effect
highli
signific
result
obtain
analysi
varianc
consid
variabl
probabl
valu
fit
linear
model
rang
sod
r
lnfod
r
lnsvn
r
lsm
three
depend
variabl
five
experiment
group
shown
tabl
logarithm
transform
use
fecal
secretori
iga
antibodi
vn
serum
antibodi
allow
power
robust
comparison
lsm
shown
tabl
highest
lnfod
valu
observ
group
valu
differ
statist
fecal
iga
valu
group
ie
dog
vaccin
transform
variabl
origin
variabl
mean
om
also
report
mean
follow
differ
letter
differ
significantli
p
comparison
perform
bonferroni
correct
lnfod
natur
logarithm
fecal
secretori
iga
antibodi
od
lnsvn
natur
logarithm
serum
antibodi
determin
vn
titer
sod
serum
antibodi
determin
elisa
od
b
descript
group
see
tabl
footnot
b
iga
ccvinfect
vaccin
dog
oronas
rout
compar
observ
natur
infect
dog
group
intermedi
valu
found
group
b
valu
differ
statist
group
e
lowest
lnfod
valu
observ
group
c
e
valu
experiment
group
experiment
group
significantli
differ
group
c
e
signific
differ
found
pair
lnsvn
lsm
except
experiment
group
b
among
three
vaccin
group
highest
lnsvn
valu
correspond
best
antibodi
respons
found
group
trend
lesssignific
differ
observ
sod
variabl
case
origin
mean
report
tabl
sinc
correspond
lsm
obtain
oneway
analysi
varianc
directli
fit
serum
antibodi
level
signific
differ
detect
c
group
show
lowest
antibodi
valu
b
group
anoth
signific
differ
observ
respons
group
b
e
higher
valu
observ
group
respect
two
vaccin
group
also
confirm
case
statist
differ
group
group
c
lsm
particularli
signific
ccv
consid
common
caus
mild
sever
gastroenter
pup
extens
viral
replic
occur
primarili
epithelium
small
intestin
howev
littl
known
immun
mechan
involv
protect
antibodi
produc
gutassoci
lymphoid
tissu
import
effector
immun
respons
enter
pathogen
coronavirus
studi
role
serum
antibodi
predictor
suscept
coronaviru
infect
ill
yield
ambigu
result
role
coproantibodi
rotaviru
infect
vaccin
investig
sever
laboratori
conflict
result
recent
studi
demonstr
fecal
system
iga
essenti
protect
rotaviru
infect
suggest
absenc
iga
igg
also
may
play
signific
role
protect
mucos
pathogen
result
studi
show
fecal
iga
involv
immun
protect
ccv
infect
well
known
ml
vaccin
administ
oronas
rout
induc
develop
serolog
mainli
mucos
immun
respons
confer
protect
reinfect
present
studi
dog
inocul
oronas
rout
ml
vaccin
group
develop
iga
level
gut
higher
level
observ
fece
dog
inocul
vaccin
intramuscular
rout
group
c
dog
inocul
inactiv
ccv
vaccin
group
e
previou
studi
dog
includ
group
present
studi
fulli
protect
challeng
ccv
field
strain
sinc
challeng
viru
detect
either
viru
isol
pcr
assay
therefor
seem
plausibl
protect
observ
dog
may
relat
level
fecal
iga
antibodi
ccv
contrast
dog
inocul
intramuscularli
ml
ccv
vaccin
group
c
particularli
dog
inocul
inactiv
ccv
vaccin
group
e
develop
low
level
fecal
iga
provid
partial
group
c
insignific
group
e
protect
mucos
immun
interest
fecal
iga
level
natur
infect
dog
group
higher
experiment
infect
dog
group
b
result
may
consequ
recent
describ
new
genotyp
ccv
tent
name
ccv
type
viral
type
frequent
detect
fece
natur
infect
pup
instanc
dog
found
simultan
infect
genotyp
ccv
type
ii
pratelli
n
decaro
tinelli
v
martella
g
elia
tempesta
f
ciron
c
buonavoglia
submit
public
sinc
experiment
infect
carri
ccv
type
ii
strain
low
iga
level
fece
dog
group
b
may
inde
consequ
singl
infect
dog
field
frequent
found
infect
ccv
genotyp
observ
intestin
infect
result
studi
show
direct
relationship
level
intestin
iga
antibodi
ccv
degre
protect
infect
dog
observ
previou
experi
assum
fecal
iga
play
import
protect
role
ccv
infect
seem
import
evalu
vaccin
regard
vaccin
type
ml
inactiv
inocul
rout
evalu
fecal
iga
antibodi
level
rather
serum
antibodi
level
appear
effici
meaning
way
evalu
protect
dog
ccv
infect
